Harrow Health, Inc.HROWNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+68.6%/yr
Quarterly compound
Percentile
P95
Near historical high
vs 3Y Ago
4.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 554.55% |
| Q3 2025 | -80.36% |
| Q2 2025 | 128.00% |
| Q1 2025 | -363.16% |
| Q4 2024 | 258.33% |
| Q3 2024 | 33.33% |
| Q2 2024 | 52.63% |
| Q1 2024 | -46.15% |
| Q4 2023 | -100.00% |
| Q3 2023 | 7.14% |
| Q2 2023 | 36.36% |
| Q1 2023 | -683.55% |
| Q4 2022 | 115.71% |
| Q3 2022 | -4.35% |
| Q2 2022 | -155.56% |
| Q1 2022 | 66.67% |
| Q4 2021 | 12.90% |
| Q3 2021 | -181.82% |
| Q2 2021 | -1200.00% |
| Q1 2021 | -75.00% |
| Q4 2020 | -87.88% |
| Q3 2020 | 3686.96% |
| Q2 2020 | 98.16% |
| Q1 2020 | -272.41% |
| Q4 2019 | 164.44% |
| Q3 2019 | -377.20% |
| Q2 2019 | -120.50% |
| Q1 2019 | -65.15% |
| Q4 2018 | 1200.00% |
| Q3 2018 | -200.00% |
| Q2 2018 | 170.59% |
| Q1 2018 | -30.77% |
| Q4 2017 | 53.57% |
| Q3 2017 | -500.00% |
| Q2 2017 | 126.92% |
| Q1 2017 | 18.75% |
| Q4 2016 | -10.34% |
| Q3 2016 | 17.14% |
| Q2 2016 | 18.60% |
| Q1 2016 | 12.24% |